Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130
- PMID: 1438305
- PMCID: PMC50470
- DOI: 10.1073/pnas.89.22.10998
Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130
Abstract
Functional pleiotropy and redundancy are characteristic features of cytokines. To understand the signaling mechanisms of such cytokines, we have proposed a two-chain interleukin (IL) 6 receptor model: IL-6 triggers the association of a ligand-binding chain (IL-6 receptor) and a nonbinding signal transducer (gp130) to form a high-affinity receptor complex, resulting in transmission of the signal by the cytoplasmic portion of gp130. This model would explain the functional redundancy of cytokines if we were to assume that gp130 interacts with several different receptor chains. Here we present data indicating that gp130 functions as a common signal transducer for IL-6, oncostatin M, leukemia inhibitory factor, and ciliary neurotrophic factor. We show that anti-gp130 monoclonal antibodies completely block the biological responses induced by all of these factors. Since leukemia inhibitory factor functions as a cholinergic differentiation factor in nerve cells, as does ciliary neurotrophic factor, these results suggest that gp130 may also play a role in the nervous system.
Similar articles
-
Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.J Biol Chem. 1996 Jun 21;271(25):14764-72. doi: 10.1074/jbc.271.25.14764. J Biol Chem. 1996. PMID: 8662918
-
[The interleukin-6 signal transducer, gp130, functioning in immune, hematopoietic, and neural systems].Nihon Rinsho. 1992 Aug;50(8):1802-10. Nihon Rinsho. 1992. PMID: 1433971 Review. Japanese.
-
Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.FEBS Lett. 2000 Feb 25;468(2-3):120-4. doi: 10.1016/s0014-5793(00)01205-9. FEBS Lett. 2000. PMID: 10692570
-
Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1.Blood. 1996 Mar 1;87(5):1851-4. Blood. 1996. PMID: 8634432
-
gp130 Cytokine family and bone cells.Cytokine. 2000 Oct;12(10):1455-68. doi: 10.1006/cyto.2000.0747. Cytokine. 2000. PMID: 11023660 Review.
Cited by
-
Molecular analysis of signaling events mediated by the cytoplasmic domain of leukemia inhibitory factor receptor alpha subunit.Mol Cell Biochem. 2004 Mar;258(1-2):15-23. doi: 10.1023/b:mcbi.0000012829.10405.e1. Mol Cell Biochem. 2004. PMID: 15030166
-
Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains.J Clin Invest. 1994 Dec;94(6):2317-25. doi: 10.1172/JCI117596. J Clin Invest. 1994. PMID: 7989587 Free PMC article.
-
Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells.J Virol. 2008 Sep;82(17):8771-9. doi: 10.1128/JVI.00766-08. Epub 2008 Jun 25. J Virol. 2008. PMID: 18579585 Free PMC article.
-
Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines.Thorax. 2000 Aug;55(8):678-84. doi: 10.1136/thorax.55.8.678. Thorax. 2000. PMID: 10899245 Free PMC article.
-
Investigating hypothetical products from noncoding frames (HyPNoFs).J Mol Evol. 1995 Jun;40(6):570-7. doi: 10.1007/BF00160503. J Mol Evol. 1995. PMID: 7543950
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources